628 related articles for article (PubMed ID: 21163515)
1. Tight junction defects in patients with atopic dermatitis.
De Benedetto A; Rafaels NM; McGirt LY; Ivanov AI; Georas SN; Cheadle C; Berger AE; Zhang K; Vidyasagar S; Yoshida T; Boguniewicz M; Hata T; Schneider LC; Hanifin JM; Gallo RL; Novak N; Weidinger S; Beaty TH; Leung DY; Barnes KC; Beck LA
J Allergy Clin Immunol; 2011 Mar; 127(3):773-86.e1-7. PubMed ID: 21163515
[TBL] [Abstract][Full Text] [Related]
2. Claudin-1 decrease impacts epidermal barrier function in atopic dermatitis lesions dose-dependently.
Bergmann S; von Buenau B; Vidal-Y-Sy S; Haftek M; Wladykowski E; Houdek P; Lezius S; Duplan H; Bäsler K; Dähnhardt-Pfeiffer S; Gorzelanny C; Schneider SW; Rodriguez E; Stölzl D; Weidinger S; Brandner JM
Sci Rep; 2020 Feb; 10(1):2024. PubMed ID: 32029783
[TBL] [Abstract][Full Text] [Related]
3. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.
Kuo IH; Carpenter-Mendini A; Yoshida T; McGirt LY; Ivanov AI; Barnes KC; Gallo RL; Borkowski AW; Yamasaki K; Leung DY; Georas SN; De Benedetto A; Beck LA
J Invest Dermatol; 2013 Apr; 133(4):988-98. PubMed ID: 23223142
[TBL] [Abstract][Full Text] [Related]
4. Enolase-1 expression in the stratum corneum is elevated with parakeratosis of atopic dermatitis and disrupts the cellular tight junction barrier in keratinocytes.
Tohgasaki T; Ozawa N; Yoshino T; Ishiwatari S; Matsukuma S; Yanagi S; Fukuda H
Int J Cosmet Sci; 2018 Apr; 40(2):178-186. PubMed ID: 29430682
[TBL] [Abstract][Full Text] [Related]
5. Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.
Yuki T; Tobiishi M; Kusaka-Kikushima A; Ota Y; Tokura Y
PLoS One; 2016; 11(9):e0161759. PubMed ID: 27588419
[TBL] [Abstract][Full Text] [Related]
6. IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes.
Ryu WI; Lee H; Bae HC; Jeon J; Ryu HJ; Kim J; Kim JH; Son JW; Kim J; Imai Y; Yamanishi K; Jeong SH; Son SW
J Dermatol Sci; 2018 Jun; 90(3):313-322. PubMed ID: 29534857
[TBL] [Abstract][Full Text] [Related]
7. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
[TBL] [Abstract][Full Text] [Related]
8. Effects of mucopolysaccharide polysulphate on tight junction barrier in human epidermal keratinocytes.
Fujikawa M; Sugimoto H; Tamura R; Fujikawa K; Yamagishi A; Ueda Y
Exp Dermatol; 2022 Nov; 31(11):1676-1684. PubMed ID: 35770317
[TBL] [Abstract][Full Text] [Related]
9. Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis.
Gruber R; Börnchen C; Rose K; Daubmann A; Volksdorf T; Wladykowski E; Vidal-Y-Sy S; Peters EM; Danso M; Bouwstra JA; Hennies HC; Moll I; Schmuth M; Brandner JM
Am J Pathol; 2015 Oct; 185(10):2777-89. PubMed ID: 26319240
[TBL] [Abstract][Full Text] [Related]
10. The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function.
Akiyama T; Niyonsaba F; Kiatsurayanon C; Nguyen TT; Ushio H; Fujimura T; Ueno T; Okumura K; Ogawa H; Ikeda S
J Innate Immun; 2014; 6(6):739-53. PubMed ID: 24862212
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent role of claudin-1 in vivo in orchestrating features of atopic dermatitis.
Tokumasu R; Yamaga K; Yamazaki Y; Murota H; Suzuki K; Tamura A; Bando K; Furuta Y; Katayama I; Tsukita S
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4061-8. PubMed ID: 27342862
[TBL] [Abstract][Full Text] [Related]
12. Tight junction protein claudin-4 is modulated via ΔNp63 in human keratinocytes.
Kubo T; Sugimoto K; Kojima T; Sawada N; Sato N; Ichimiya S
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):205-11. PubMed ID: 25449274
[TBL] [Abstract][Full Text] [Related]
13. The tight junction gene Claudin-1 is associated with atopic dermatitis among Ethiopians.
Asad S; Winge MC; Wahlgren CF; Bilcha KD; Nordenskjöld M; Taylan F; Bradley M
J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):1939-1941. PubMed ID: 27581203
[TBL] [Abstract][Full Text] [Related]
14. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis.
Yoshida K; Kubo A; Fujita H; Yokouchi M; Ishii K; Kawasaki H; Nomura T; Shimizu H; Kouyama K; Ebihara T; Nagao K; Amagai M
J Allergy Clin Immunol; 2014 Oct; 134(4):856-64. PubMed ID: 25282566
[TBL] [Abstract][Full Text] [Related]
15. Scratching damages tight junctions through the Akt-claudin 1 axis in atopic dermatitis.
Hu XQ; Tang Y; Ju Y; Zhang XY; Yan JJ; Wang CM; Yang Y; Zhu C; Tang ZX; Zhou Y; Yu G
Clin Exp Dermatol; 2021 Jan; 46(1):74-81. PubMed ID: 32668051
[TBL] [Abstract][Full Text] [Related]
16. Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice.
Sugawara T; Iwamoto N; Akashi M; Kojima T; Hisatsune J; Sugai M; Furuse M
J Dermatol Sci; 2013 Apr; 70(1):12-8. PubMed ID: 23433550
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib, a proteasome inhibitor, alleviates atopic dermatitis by increasing claudin 1 protein expression.
Kim YE; Cho N; Cheon S; Kim KK
Biochem Biophys Res Commun; 2017 Nov; 493(1):744-750. PubMed ID: 28859979
[TBL] [Abstract][Full Text] [Related]
18. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes.
Kirschner N; Rosenthal R; Furuse M; Moll I; Fromm M; Brandner JM
J Invest Dermatol; 2013 May; 133(5):1161-9. PubMed ID: 23407391
[TBL] [Abstract][Full Text] [Related]
19. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice.
Furuse M; Hata M; Furuse K; Yoshida Y; Haratake A; Sugitani Y; Noda T; Kubo A; Tsukita S
J Cell Biol; 2002 Mar; 156(6):1099-111. PubMed ID: 11889141
[TBL] [Abstract][Full Text] [Related]
20. CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders.
Arnold KA; Moran MC; Shi H; van Vlijmen-Willems IMJJ; Rodijk-Olthuis D; Smits JPH; Brewer MG
Exp Dermatol; 2024 May; 33(5):e15084. PubMed ID: 38711223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
